AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Buying for a business?Offer from Amazon

Get business pricing on tech for your team

  • Business-only prices and quantity discounts
  • Tax-exempt purchasing
  • Multiple users, one account, clear invoices
As an affiliate, we earn on qualifying purchases.

Medicare has launched a new payment model that incentivizes AI-driven healthcare outcomes, marking a significant shift in federal healthcare reimbursement. Most of the tech sector has yet to recognize this development, which could impact AI innovation and healthcare delivery.

Medicare’s new payment model, called ACCESS, officially went live on July 5, 2023, introducing outcome-based reimbursements for AI-enabled healthcare services. This development marks the first time the federal program has created a mechanism to pay for AI-driven patient monitoring and intervention, fundamentally transforming healthcare reimbursement.

ACCESS—short for Advancing Chronic Care with Effective, Scalable Solutions—is a 10-year CMS initiative testing a payment structure that rewards organizations for achieving measurable health outcomes rather than traditional activity-based billing. Participating organizations, including startups like Pair Team, receive predictable payments for managing chronic conditions and only earn full compensation when patients meet specific health goals such as blood pressure reduction or decreased hospital visits.

Pair Team, which has been developing its model since 2019, employs a voice AI agent named Flora to handle patient check-ins, referrals, and engagement between clinical visits. The program’s design was influenced by former startup founders within CMS, aiming to foster innovation through outcome-based payments and increased competition. The move is significant because it creates a formal reimbursement pathway for AI tools, which previously relied on time-based billing models that did not account for AI-driven interventions.

Why It Matters

This shift in Medicare reimbursement could accelerate AI adoption in healthcare by providing a sustainable financial model for AI-enabled care. For startups and established providers alike, it opens the door to scaling AI solutions that improve patient outcomes without being limited by traditional fee-for-service constraints. However, it also raises concerns about data security, given the sensitive nature of health information processed under the program, and the financial viability for organizations that cannot fully automate their services.

Products Worth Considering

LG UltraGear 32GX850A-B 32-Inch 4K UHD Glossy OLED Gaming Monitor

LG UltraGear 32GX850A-B 32-Inch 4K UHD Glossy OLED Gaming Monitor

Jackery Explorer 500 v2 Portable Power Station, 512Wh, 500W

Jackery Explorer 500 v2 Portable Power Station, 512Wh, 500W

As an affiliate, we earn on qualifying purchases.

Background

Prior to this, Medicare primarily reimbursed healthcare providers based on the time spent with patients, with no mechanism to pay for AI or remote monitoring tools. The ACCESS program is part of CMS’s broader effort to modernize healthcare payments and promote innovation, especially for managing chronic and complex conditions. The program was designed by former startup operators within CMS, reflecting a push for outcome-based models and increased competition, but has faced skepticism due to mixed results from previous CMS innovation initiatives.

Neil Batlivala’s company, Pair Team, exemplifies the new approach by integrating AI with community-based care for vulnerable populations, showing promising results in reducing hospital and ER visits. The deployment of Flora, an AI voice agent, has demonstrated the potential for AI to serve as a 24/7 patient companion and intervention tool, especially for underserved groups.

“The government is creating swim lanes for AI innovation in traditionally regulated industries. The best solution wins, which, in healthcare, has not always been the case.”

— Neil Batlivala, CEO of Pair Team

“This program is designed to test whether outcome-based payments can incentivize meaningful improvements in chronic care management.”

— Abe Sutton, CMS Innovation Center Director

What Remains Unclear

It remains unclear how widespread adoption will be beyond initial participants and whether the model will lead to cost savings or improved health outcomes at scale. Data security concerns persist given the sensitive information involved, and the long-term sustainability of outcome-based payments remains uncertain, especially considering CMS’s past mixed results with innovation programs.

What’s Next

Next steps include monitoring the performance of initial participants, evaluating patient outcomes, and assessing the financial sustainability of the model. CMS plans to expand participation and refine the program based on early results, with potential policy adjustments to address data security and reimbursement rates.

Key Questions

What is the ACCESS program?

ACCESS is a 10-year CMS initiative that tests outcome-based payment models for chronic care, including AI-driven interventions, to improve patient health and reduce costs.

Why is this development significant for AI in healthcare?

It creates a formal reimbursement pathway for AI tools, which previously lacked a sustainable financial model, potentially accelerating AI adoption and innovation in healthcare.

What are the main risks associated with this program?

Data security concerns due to sensitive health information being processed by federal infrastructure, and questions about whether the payment model can deliver cost savings and better outcomes at scale.

Who are the initial participants in the program?

Participants include AI startups like Pair Team, virtual nutrition providers, connected device companies, and wearable makers, all testing different approaches to outcome-based care.

What happens next for the program?

CMS will evaluate early results, expand participation, and refine the model, with the goal of establishing a long-term, scalable framework for AI-enabled healthcare reimbursement.

You May Also Like

AI for Personalized Allergy Management

Sensing your unique allergy profile, AI transforms management with personalized insights and predictions—discover how this innovative technology can improve your health.

The Impact Of AI Collaboration Between Novo Nordisk And Anthropic On Healthcare

Novo Nordisk’s collaboration with Anthropic signals a shift toward AI-driven drug discovery, impacting healthcare innovation and market dynamics.

Generative AI in Healthcare: ChatGPT and Beyond in Medicine

With generative AI like ChatGPT revolutionizing healthcare, exploring its full potential could transform medicine—are you ready to discover how?

How AI Is Helping Researchers Find New Drug Targets Faster

Unlock how AI accelerates drug target discovery by analyzing vast data, revealing insights, and transforming future treatments—discover the breakthroughs shaping medicine today.